DMT Therapy for Substance Misuse: Meta‐Analysis Findings

TLDR

A 2026 meta‑analysis of 1960‑2024 studies found that DMT, especially when paired with psychotherapy, shows a large reduction in drug use (g = 1.35) and a moderate reduction in alcohol use (g = 0.65). The evidence is graded A but carries high risk of bias and heterogeneity, so the findings remain preliminary and should not be taken as proof of efficacy.

The Big Takeaway

The 2026 meta‑analysis shows that DMT, when combined with psychotherapy, can cut drug use by a large margin (effect size g = 1.35). For alcohol, the effect is smaller but still significant (g = 0.65). These numbers come from 17 studies out of 1960‑2024, highlighting how rare rigorous research on this topic is.

What the Study Says

Research – Wallace et al. published a systematic review in the Journal of Psychopharmacology (2026‑04‑12). They searched PubMed, PsycINFO, Web of Science, and EBSCO for studies using the psychedelic N,N‑dimethyltryptamine (DMT) to treat substance misuse.
Outcome – The pooled effect size for overall substance‑use reduction was large (g = 0.94, 95 % CI 0.56–1.31, p < 0.0001). Drug‑specific effects were even larger (g = 1.35, 95 % CI 0.63–2.07); alcohol reductions were moderate (g = 0.65, 95 % CI 0.31–0.99). Studies that included psychotherapy showed markedly stronger effects (g = 1.38, 95 % CI 1.06–1.71) than those that did not (g = 0.60, 95 % CI 0.09–1.12). Heterogeneity was very high (I² = 96.9 %); no publication bias was detected.
Strength – The evidence is graded A, indicating a meta‑analysis, but the included studies carry a high risk of bias and substantial heterogeneity. Consequently, the findings are preliminary and should not be taken as conclusive proof of efficacy.
Explain – These results suggest that, in the limited studies reviewed, DMT combined with psychotherapy may help reduce drug and alcohol use. However, the evidence does not establish that DMT is an effective or safe treatment for substance misuse in general, nor does it confirm long‑term benefits or rule out methodological flaws that could inflate the effect sizes.

How the Studies Were Conducted

The review included 17 studies, ranging from early case reports to small pilot trials. Most used a single‑dose DMT administration, with varying psychotherapeutic frameworks (e.g., supportive counseling, experiential therapy). Outcomes were typically measured via self‑report drug/alcohol use questionnaires administered pre‑ and post‑intervention, with follow‑ups ranging from weeks to months.

A Mid‑Article Hook

Despite the impressive effect sizes, the analysis covered only 17 studies out of more than 2000 that were initially identified. This gap underscores how sparse high‑quality research on DMT and substance misuse remains.

What It Does NOT Prove

• Causality – The studies do not prove that DMT alone causes reductions in substance use; other factors (e.g., participant motivation, therapist influence) could contribute.
• Long‑Term Efficacy – None of the included studies had follow‑ups beyond a few months, so sustained benefits remain unverified.
• Safety Profile – While no serious adverse events were reported in these studies, the review does not provide a comprehensive safety assessment.
• Generalizability – The high heterogeneity and small sample sizes limit the ability to generalize findings to broader populations or to clinical practice.

Evidence at a Glance

Evidence Grade	Risk Level	Confidence (Plain English)
A	High	The analysis is based on a meta‑analysis, but the included studies have high risk of bias and heterogeneity, so confidence in the reported effect sizes is moderate to low.

Conclusion

The 2026 meta‑analysis indicates that DMT, particularly when paired with psychotherapy, shows promise for reducing drug and alcohol use in the limited research available. However, methodological limitations, high heterogeneity, and lack of long‑term data mean that these findings should be viewed as preliminary. Further rigorous, controlled trials are needed before any definitive claims about efficacy can be made.

Frequently Asked Questions

What is DMT?

DMT (N,N‑dimethyltryptamine) is a naturally occurring psychedelic compound found in certain plants and animals. It is known for producing intense, short‑duration perceptual experiences.

How was DMT administered in the reviewed studies?

Most studies used a single oral or intravenous dose of DMT, often within a controlled setting and accompanied by a psychotherapeutic framework. Exact dosing varied across studies.

What does an effect size of g = 0.94 mean?

An effect size (Cohen’s g) of 0.94 indicates a large reduction in substance use relative to baseline or control conditions, but it is a statistical estimate that does not equate to clinical significance.

Is DMT therapy approved for treating substance misuse?

No. DMT remains a Schedule I controlled substance in many jurisdictions, and its use outside of approved research contexts is illegal.

Why is the risk of bias high in these studies?

Many studies lacked blinding, had small sample sizes, and used self‑report measures, all of which can inflate effect estimates and reduce internal validity.

Internal‑Link Suggestions

• Understanding Psychedelic Therapy → /psychedelic-therapy-overview
• Substance Misuse Treatment Options → /treatment-options-substance-misuse
• Meta‑Analysis Explained → /meta-analysis-basics
• Psychotherapy in Substance Abuse → /psychotherapy-substance-abuse

Sources

• Efficacy of N, N-dimethyltryptamine (DMT) psychedelic therapy for substance misuse: A systematic review and meta‑analysis – Journal of Psychopharmacology

Educational Disclaimer

This article is for informational and educational purposes only. It is not
medical advice, mental health advice, diagnosis, treatment guidance, or a
recommendation to use any substance, supplement, therapy, or protocol.

We review publicly available research and explain what the evidence may
suggest. Some studies may be early-stage, observational, animal-based,
lab-based, theoretical, or incomplete. Always consult a qualified
professional before making health-related decisions.

If you or someone you know is struggling, you are not alone. In the US, call or text 988 (Suicide & Crisis Lifeline). Elsewhere, contact your local emergency or crisis service.

Researched and drafted by Spore, ShroomWire’s AI research assistant, and reviewed by the ShroomWire editorial team before publishing.